TipRanks
Go Ultimate55% OFF

Laboratorios Farmaceuticos Rovi (ROVIN) Balance Sheet

Laboratorios Farmaceuticos Rovi Balance Sheet

Laboratorios Farmaceuticos Rovi's total assets for Q2 2026 were $1.13B, an increase of 21.67% from the previous quarter. MX:ROVIN total liabilities were $409.97M for the fiscal quarter, a 71.12% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 955.69M$ 832.02M$ 799.88M$ 878.70M$ 732.68M
$ 276.79M$ 250.48M$ 256.39M$ 357.32M$ 261.70M
$ 675.46M$ 581.54M$ 543.49M$ 521.38M$ 470.98M

Currency in EUR

Laboratorios Farmaceuticos Rovi Debt to Assets

0400M800M1.2B24 %30 %36 %42 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets